Cargando…

Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model

Countermeasures to prevent and treat coronavirus disease 2019 (COVID-19) are a global health priority. We enrolled a cohort of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–recovered participants, developed neutralization assays to investigate antibody responses, adapted our high-thro...

Descripción completa

Detalles Bibliográficos
Autores principales: Rogers, Thomas F., Zhao, Fangzhu, Huang, Deli, Beutler, Nathan, Burns, Alison, He, Wan-ting, Limbo, Oliver, Smith, Chloe, Song, Ge, Woehl, Jordan, Yang, Linlin, Abbott, Robert K., Callaghan, Sean, Garcia, Elijah, Hurtado, Jonathan, Parren, Mara, Peng, Linghang, Ramirez, Sydney, Ricketts, James, Ricciardi, Michael J., Rawlings, Stephen A., Wu, Nicholas C., Yuan, Meng, Smith, Davey M., Nemazee, David, Teijaro, John R., Voss, James E., Wilson, Ian A., Andrabi, Raiees, Briney, Bryan, Landais, Elise, Sok, Devin, Jardine, Joseph G., Burton, Dennis R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299280/
https://www.ncbi.nlm.nih.gov/pubmed/32540903
http://dx.doi.org/10.1126/science.abc7520
_version_ 1783547355121844224
author Rogers, Thomas F.
Zhao, Fangzhu
Huang, Deli
Beutler, Nathan
Burns, Alison
He, Wan-ting
Limbo, Oliver
Smith, Chloe
Song, Ge
Woehl, Jordan
Yang, Linlin
Abbott, Robert K.
Callaghan, Sean
Garcia, Elijah
Hurtado, Jonathan
Parren, Mara
Peng, Linghang
Ramirez, Sydney
Ricketts, James
Ricciardi, Michael J.
Rawlings, Stephen A.
Wu, Nicholas C.
Yuan, Meng
Smith, Davey M.
Nemazee, David
Teijaro, John R.
Voss, James E.
Wilson, Ian A.
Andrabi, Raiees
Briney, Bryan
Landais, Elise
Sok, Devin
Jardine, Joseph G.
Burton, Dennis R.
author_facet Rogers, Thomas F.
Zhao, Fangzhu
Huang, Deli
Beutler, Nathan
Burns, Alison
He, Wan-ting
Limbo, Oliver
Smith, Chloe
Song, Ge
Woehl, Jordan
Yang, Linlin
Abbott, Robert K.
Callaghan, Sean
Garcia, Elijah
Hurtado, Jonathan
Parren, Mara
Peng, Linghang
Ramirez, Sydney
Ricketts, James
Ricciardi, Michael J.
Rawlings, Stephen A.
Wu, Nicholas C.
Yuan, Meng
Smith, Davey M.
Nemazee, David
Teijaro, John R.
Voss, James E.
Wilson, Ian A.
Andrabi, Raiees
Briney, Bryan
Landais, Elise
Sok, Devin
Jardine, Joseph G.
Burton, Dennis R.
author_sort Rogers, Thomas F.
collection PubMed
description Countermeasures to prevent and treat coronavirus disease 2019 (COVID-19) are a global health priority. We enrolled a cohort of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–recovered participants, developed neutralization assays to investigate antibody responses, adapted our high-throughput antibody generation pipeline to rapidly screen more than 1800 antibodies, and established an animal model to test protection. We isolated potent neutralizing antibodies (nAbs) to two epitopes on the receptor binding domain (RBD) and to distinct non-RBD epitopes on the spike (S) protein. As indicated by maintained weight and low lung viral titers in treated animals, the passive transfer of a nAb provides protection against disease in high-dose SARS-CoV-2 challenge in Syrian hamsters. The study suggests a role for nAbs in prophylaxis, and potentially therapy, of COVID-19. The nAbs also define protective epitopes to guide vaccine design.
format Online
Article
Text
id pubmed-7299280
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher American Association for the Advancement of Science
record_format MEDLINE/PubMed
spelling pubmed-72992802020-06-29 Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model Rogers, Thomas F. Zhao, Fangzhu Huang, Deli Beutler, Nathan Burns, Alison He, Wan-ting Limbo, Oliver Smith, Chloe Song, Ge Woehl, Jordan Yang, Linlin Abbott, Robert K. Callaghan, Sean Garcia, Elijah Hurtado, Jonathan Parren, Mara Peng, Linghang Ramirez, Sydney Ricketts, James Ricciardi, Michael J. Rawlings, Stephen A. Wu, Nicholas C. Yuan, Meng Smith, Davey M. Nemazee, David Teijaro, John R. Voss, James E. Wilson, Ian A. Andrabi, Raiees Briney, Bryan Landais, Elise Sok, Devin Jardine, Joseph G. Burton, Dennis R. Science Research Articles Countermeasures to prevent and treat coronavirus disease 2019 (COVID-19) are a global health priority. We enrolled a cohort of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–recovered participants, developed neutralization assays to investigate antibody responses, adapted our high-throughput antibody generation pipeline to rapidly screen more than 1800 antibodies, and established an animal model to test protection. We isolated potent neutralizing antibodies (nAbs) to two epitopes on the receptor binding domain (RBD) and to distinct non-RBD epitopes on the spike (S) protein. As indicated by maintained weight and low lung viral titers in treated animals, the passive transfer of a nAb provides protection against disease in high-dose SARS-CoV-2 challenge in Syrian hamsters. The study suggests a role for nAbs in prophylaxis, and potentially therapy, of COVID-19. The nAbs also define protective epitopes to guide vaccine design. American Association for the Advancement of Science 2020-08-21 2020-06-15 /pmc/articles/PMC7299280/ /pubmed/32540903 http://dx.doi.org/10.1126/science.abc7520 Text en Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works https://creativecommons.org/licenses/by/4.0/ https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution license (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Rogers, Thomas F.
Zhao, Fangzhu
Huang, Deli
Beutler, Nathan
Burns, Alison
He, Wan-ting
Limbo, Oliver
Smith, Chloe
Song, Ge
Woehl, Jordan
Yang, Linlin
Abbott, Robert K.
Callaghan, Sean
Garcia, Elijah
Hurtado, Jonathan
Parren, Mara
Peng, Linghang
Ramirez, Sydney
Ricketts, James
Ricciardi, Michael J.
Rawlings, Stephen A.
Wu, Nicholas C.
Yuan, Meng
Smith, Davey M.
Nemazee, David
Teijaro, John R.
Voss, James E.
Wilson, Ian A.
Andrabi, Raiees
Briney, Bryan
Landais, Elise
Sok, Devin
Jardine, Joseph G.
Burton, Dennis R.
Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model
title Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model
title_full Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model
title_fullStr Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model
title_full_unstemmed Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model
title_short Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model
title_sort isolation of potent sars-cov-2 neutralizing antibodies and protection from disease in a small animal model
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299280/
https://www.ncbi.nlm.nih.gov/pubmed/32540903
http://dx.doi.org/10.1126/science.abc7520
work_keys_str_mv AT rogersthomasf isolationofpotentsarscov2neutralizingantibodiesandprotectionfromdiseaseinasmallanimalmodel
AT zhaofangzhu isolationofpotentsarscov2neutralizingantibodiesandprotectionfromdiseaseinasmallanimalmodel
AT huangdeli isolationofpotentsarscov2neutralizingantibodiesandprotectionfromdiseaseinasmallanimalmodel
AT beutlernathan isolationofpotentsarscov2neutralizingantibodiesandprotectionfromdiseaseinasmallanimalmodel
AT burnsalison isolationofpotentsarscov2neutralizingantibodiesandprotectionfromdiseaseinasmallanimalmodel
AT hewanting isolationofpotentsarscov2neutralizingantibodiesandprotectionfromdiseaseinasmallanimalmodel
AT limbooliver isolationofpotentsarscov2neutralizingantibodiesandprotectionfromdiseaseinasmallanimalmodel
AT smithchloe isolationofpotentsarscov2neutralizingantibodiesandprotectionfromdiseaseinasmallanimalmodel
AT songge isolationofpotentsarscov2neutralizingantibodiesandprotectionfromdiseaseinasmallanimalmodel
AT woehljordan isolationofpotentsarscov2neutralizingantibodiesandprotectionfromdiseaseinasmallanimalmodel
AT yanglinlin isolationofpotentsarscov2neutralizingantibodiesandprotectionfromdiseaseinasmallanimalmodel
AT abbottrobertk isolationofpotentsarscov2neutralizingantibodiesandprotectionfromdiseaseinasmallanimalmodel
AT callaghansean isolationofpotentsarscov2neutralizingantibodiesandprotectionfromdiseaseinasmallanimalmodel
AT garciaelijah isolationofpotentsarscov2neutralizingantibodiesandprotectionfromdiseaseinasmallanimalmodel
AT hurtadojonathan isolationofpotentsarscov2neutralizingantibodiesandprotectionfromdiseaseinasmallanimalmodel
AT parrenmara isolationofpotentsarscov2neutralizingantibodiesandprotectionfromdiseaseinasmallanimalmodel
AT penglinghang isolationofpotentsarscov2neutralizingantibodiesandprotectionfromdiseaseinasmallanimalmodel
AT ramirezsydney isolationofpotentsarscov2neutralizingantibodiesandprotectionfromdiseaseinasmallanimalmodel
AT rickettsjames isolationofpotentsarscov2neutralizingantibodiesandprotectionfromdiseaseinasmallanimalmodel
AT ricciardimichaelj isolationofpotentsarscov2neutralizingantibodiesandprotectionfromdiseaseinasmallanimalmodel
AT rawlingsstephena isolationofpotentsarscov2neutralizingantibodiesandprotectionfromdiseaseinasmallanimalmodel
AT wunicholasc isolationofpotentsarscov2neutralizingantibodiesandprotectionfromdiseaseinasmallanimalmodel
AT yuanmeng isolationofpotentsarscov2neutralizingantibodiesandprotectionfromdiseaseinasmallanimalmodel
AT smithdaveym isolationofpotentsarscov2neutralizingantibodiesandprotectionfromdiseaseinasmallanimalmodel
AT nemazeedavid isolationofpotentsarscov2neutralizingantibodiesandprotectionfromdiseaseinasmallanimalmodel
AT teijarojohnr isolationofpotentsarscov2neutralizingantibodiesandprotectionfromdiseaseinasmallanimalmodel
AT vossjamese isolationofpotentsarscov2neutralizingantibodiesandprotectionfromdiseaseinasmallanimalmodel
AT wilsoniana isolationofpotentsarscov2neutralizingantibodiesandprotectionfromdiseaseinasmallanimalmodel
AT andrabiraiees isolationofpotentsarscov2neutralizingantibodiesandprotectionfromdiseaseinasmallanimalmodel
AT brineybryan isolationofpotentsarscov2neutralizingantibodiesandprotectionfromdiseaseinasmallanimalmodel
AT landaiselise isolationofpotentsarscov2neutralizingantibodiesandprotectionfromdiseaseinasmallanimalmodel
AT sokdevin isolationofpotentsarscov2neutralizingantibodiesandprotectionfromdiseaseinasmallanimalmodel
AT jardinejosephg isolationofpotentsarscov2neutralizingantibodiesandprotectionfromdiseaseinasmallanimalmodel
AT burtondennisr isolationofpotentsarscov2neutralizingantibodiesandprotectionfromdiseaseinasmallanimalmodel